Browsing: Pharmas
(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share…
© 2024 American CEO Club. All Rights Reserved.
(Reuters) -Vanda Pharmaceuticals on Monday rejected UK-based Cycle Pharmaceuticals’ second takeover proposal, which values the drugmaker at $8 per share…
Login to your account below.